← Open Payments lookup

SARA DUNCAN: Open Payments

NPI 1285108662 · CARRIERE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$646 in 38 payments from 11 companies in 2025. Trend: 2023 $646 · 2024 $792 · 2025 $646

Food & beverage: $646
CompanyPaymentsAmount
ABBVIE INC.18$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
Takeda Pharmaceuticals U.S.A., Inc.4$70
Neurocrine BioSciences, Inc.2$64
Corium, LLC3$61
Vanda Pharmaceuticals Inc.3$55
Kerecis Limited1$24
Otsuka America Pharmaceutical, Inc.1$23
Axsome Therapeutics, Inc.1$22
PFIZER INC.1$21

Products named: VRAYLAR, CAPLYTA, TRINTELLIX, INGREZZA, Azstarys, FANAPT, Kerecis SurgiClose, REXULTI.

Industry payments across MS — which companies pay providers there.